North America is expected to offer maximum growth opportunities with respect to retinal vein occlusion treatment. AbbVie, F. Hoffmann-La Roche Co. Ltd., and Regeneron Pharmaceuticals are some prominent players offering retinal vein occlusion treatment providers

NEWARK, Del, March 21, 2023 (GLOBE NEWSWIRE) -- The global retinal vein occlusion treatment market is likely to register a CAGR of 5.9% from 2023 to 2033. According to Future Market Insights, a valuation of US$ 2.3 billion is expected for the industry by the end of 2023. Retinal vein occlusion is among the most pervasive retinal vascular ailments in older individuals, and mainly affects people over the age of 65. Age is a significant potential risk for retinal vein occlusion. As the elderly population goes up, it is presumed that the incidence of retinal vein occlusion will increase as well.

Owing to various improved medical facilities, an expansion in the occurrence of eye disorders, technological advancements, and an upsurge in the aging population, North America held a substantial portion of the global retinal vein occlusion market in 2022. From 2023 to 2033, the Asia Pacific retinal vein occlusion market is expected to increase at a 6.5% CAGR. The rising prevalence of ocular diseases in Asia Pacific, particularly in China, Singapore, Indonesia, and other Southeast Asian countries, along with rising health expenditures, are predicted to propel market expansion in East & South Asia from 2023 to 2033. Europe is expected to have the second-largest share of the market during the forecast years. The rise of a huge older population, along with elevated healthcare spending, is driving the retinal vein occlusion market expansion in this region.

For More Insights on this Market, Get A Sample Report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-16599

The branch retinal vein occlusion segment had the highest global retinal vein occlusion therapeutics revenue growth in 2022. This segment is expected to dominate the market as the occurrence of high blood pressure, cardiovascular disease, and glaucoma rises.

Key Takeaways from the Market Study

• Global retinal vein occlusion treatment market to reach a valuation of US$ 4.7 billion in 2033
• East Asia retinal vein occlusion market is expected to expand at a CAGR of 6.5%.
• From 2018 to 2022, sales increased significantly at a CAGR of 5%.
• The random-effects gathered likelihood of RVO in Europeans over the age of 55 was 0.7%, according to a 2018 Pubmed report.
• The total number of affected people in the EU is expected to nearly double, from 900,000 in 2018 to 1.1 million in 2050.
  

“Players in the retinal vein occlusion treatment domain are increasing their capacity to produce corticosteroid drugs, which can help combat the inflammatory factors that cause edema. Healthcare professionals, on the other hand, are becoming increasingly skilled in focal laser therapy,” says FMI’s analyst.

Market Competition

Key players in the retinal vein occlusion treatment market are AbbVie, Roche, Regeneron Pharmaceuticals, Taiwan Liposome Company, Aerie Pharmaceuticals, Graybug Vision, Kodiak Sciences Inc., Chugai Pharmaceuticals, and Novartis AG among others.

• Novartis affirmed highly supportive for the initial interpretable Phase III findings of a clinical study investigating the effectiveness and protection of Beovu in December 2020. Beovu by Novartis placed Regeneron's anti-VEGF Eylea, one of the renowned treatments for diabetic macular edema, in direct competition.
• Roche is presently performing Phase III trials to examine the effectiveness and security of Faricimab in sick people with macular edema secondary to BRVO and CRVO, with the drug anticipated to be approved by 2023 based on the findings.

Want your report customized? Speak to an analyst and personalize your report according to your needs @ https://www.futuremarketinsights.com/ask-question/rep-gb-16599

Key Segments Profiled in the Retinal Vein Occlusion Treatment Industry Survey

By Drug Class:

• Ranibizumab
• Dexamethasone
• Aflibercept
• Bevacizumab

By Type:

• Central Retinal Vein Occlusion
• Branch Retinal Vein Occlusion

By Diagnosis:

• Optical Coherence Tomography
• Fundoscopic Examination
• Fluorescein Angiography
  

By End User:

• Hospitals
• Research and Academics
• Specialty Clinics
  

To Gain More Insights about this Research, Visit @ https://www.futuremarketinsights.com/reports/retinal-vein-occlusion-treatment-market

Table of Content

1. Executive Summary | Retinal Vein Occlusion Treatment Market

1.1. Global Market Outlook

1.2. Demand-side Trends

1.3. Supply-side Trends

1.4. Technology Roadmap Analysis

1.5. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

3. Market Background

3.1. Market Dynamics

3.1.1. Drivers

3.1.2. Restraints

3.1.3. Opportunity

3.1.4. Trends

3.2. Scenario Forecast

Click Here for Retinal Vein Occlusion Treatment Market 300 pages TOC Report

About the Healthcare Division at Future Market Insights

The healthcare team at Future Market Insights offers expert analysis, time efficient research, and strategic recommendations with an objective to provide authentic insights and accurate results to help clients worldwide. With a repertoire of over 100+ reports and 1 million+ data points, the team has been analyzing the industry lucidly in 50+ countries for over a decade. The team provides a brief analysis on key trends including competitive landscape, profit margin, and research development efforts. 

Have a Look at Related Reports of Healthcare domain

Medical Penlights Market Size: The global medical penlights market is projected to amass a revenue of around US$ 362.1 billion by 2032, up from US$ 261.3 billion in 2022 moving forward with a CAGR of 3.0% during the forecast period (2022-2032).

Hemostats For Wound Closure Market Share: The Hemostats For Wound Closure Market expected to register a CAGR of 6.3% during the forecast period, up from US$ 2.4 Billion in 2021 to reach a valuation of US$ 3.5 Billion by 2026.

Gel Implants Market Demand: The global gel implants market reach US$ 1.3 Billion in 2021. Demand is forecast to increase at a 3.4% CAGR over the forecast period, with the market valuation reaching US$ 1.8 Billion by 2032.

INR Test Meter Market Analysis: The global INR test meter market is expected to enjoy a valuation of US$ 1.3 Billion by the end of 2022, registering a CAGR of 6.3%, surpassing ~US$ 2.4 Billion by 2032.

Phakic Intraocular Lenses (IOL) Market Growth: The global phakic intraocular lenses (IOL) market reached US$ 344.4 Million in 2021. As per the report, sales are projected to grow at a 9.5% CAGR over the assessment period, with the market valuation reaching US$ 819.5 Million by 2032.

About Future Market Insights (FMI)

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai and has delivery centers in the UK, US, and India. FMI's latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:

Future Market Insights Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware - 19713, USA

T: +1-845-579-5705

LinkedIn| Twitter| Blogs | YouTube
For Sales Enquiries: sales@futuremarketinsights.com